Treatment of thyroid cancer with radioactive iodine: best clinics abroad

Radioactive iodine treatment uses iodine-131 to deliver radiation to thyroid tissue that takes up iodine. In cancer care it may be considered after thyroid surgery to remove remaining thyroid tissue, reduce the risk of recurrence in selected patients, or treat iodine-sensitive disease that has spread. It mainly concerns differentiated cancers, including papillary and follicular cancer. The decision depends on pathology and recurrence risk; not everyone who has thyroid cancer needs this treatment.

For treatment abroad, arrange review of the operation report, tissue findings, blood tests and available scans before making travel plans. The nuclear medicine team should explain the aim, preparation, possible adverse effects and radiation precautions. The treatment is swallowed as a capsule or liquid, but this does not make it an ordinary medication course. Hospital arrangements, contact with other people and the timing of travel need an individual plan. Continued thyroid hormone management and cancer follow-up also remain necessary.

Who may benefit from radioiodine

The specialist assesses tumour type, surgical findings, spread and the likelihood of recurrence. Some lower-risk differentiated cancers can be managed without radioiodine. Medullary and anaplastic thyroid cancers do not take up iodine in the way needed for this treatment. If differentiated cancer stops responding to radioiodine, repeating it is not automatically useful; other treatment options may be considered within an oncology assessment.

Preparation and treatment

The team reviews recent iodine-containing contrast, supplements and medicines because they can affect iodine uptake. A temporary low-iodine diet may be prescribed. Thyroid-stimulating hormone needs to be raised using an agreed medication plan or injections. Do not stop thyroid hormone or other medicines independently. Pregnancy and breastfeeding must be discussed before scheduling; therapeutic radioiodine is not given during pregnancy or breastfeeding.

Iodine-131 is taken by mouth under nuclear medicine supervision. The required activity and whether admission is necessary depend on the clinical indication and local radiation rules. A scan after treatment can help show where the iodine has accumulated. The team explains what those findings mean alongside the other results.

Precautions, risks and follow-up

For a period after treatment, radiation precautions protect others, particularly children and pregnant people. Written instructions should cover close contact, sleeping arrangements, hygiene, work and travel. Their duration varies, so accommodation and transport should be agreed before the visit.

Possible problems include nausea, neck discomfort, altered taste, dry mouth and salivary gland inflammation. Repeated or higher exposures can carry additional long-term risks, including a small risk of another cancer. Discuss fertility and future pregnancy plans. Follow-up may include thyroglobulin and antibody tests, thyroid hormone review, neck ultrasound and selected imaging. A post-treatment scan alone does not establish the final response.

Frequently asked questions

Is radioiodine necessary after every thyroid operation?

No. The reason for surgery, cancer subtype and recurrence risk determine whether it offers a worthwhile benefit.

Can I return home immediately?

Discharge and travel depend on measured radiation levels, local rules and your home circumstances. Ask for personalised written advice before booking.

Can iodine supplements replace treatment?

No. Ordinary iodine does not provide the therapeutic radiation and may interfere with preparation.

Will I still need thyroid hormone tablets?

After total thyroid removal, replacement is needed. The dose and monitoring plan are adjusted by the treating clinician.